Prestige Consumer Healthcare Inc. (FRA:PBV)

Revenue Breakdown

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
North American OTC Healthcare Revenue	927.98M	960.01M	958.26M
North American OTC Healthcare Revenue Growth	-3.34%	0.18%	-1.59%
International OTC Healthcare Revenue	175.63M	177.75M	167.10M
International OTC Healthcare Revenue Growth	-1.20%	6.38%	8.54%
Revenue (Total)	1.10B	1.14B	1.13B
Revenue (Total) Growth	-3.00%	1.10%	-0.21%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Analgesics Revenue	115.90M	117.70M	117.45M
Analgesics Revenue Growth	-1.53%	0.21%	-1.52%
Cough & Cold Revenue	102.53M	106.21M	119.02M
Cough & Cold Revenue Growth	-3.47%	-10.76%	-6.28%
Women's Health Revenue	234.50M	236.83M	240.42M
Women's Health Revenue Growth	-0.98%	-1.49%	-4.35%
Gastrointestinal Revenue	260.32M	255.94M	231.61M
Gastrointestinal Revenue Growth	1.71%	10.51%	2.22%
Eye & Ear Care Revenue	151.81M	183.32M	179.42M
Eye & Ear Care Revenue Growth	-17.19%	2.17%	4.88%
Dermatologicals Revenue	124.53M	128.95M	129.10M
Dermatologicals Revenue Growth	-3.43%	-0.12%	4.33%
Oral Care Revenue	100.15M	95.03M	96.31M
Oral Care Revenue Growth	5.38%	-1.32%	-1.35%
Other OTC Revenue	13.88M	13.78M	12.03M
Other OTC Revenue Growth	0.73%	14.58%	8.36%
Revenue (Total)	1.10B	1.14B	1.13B
Revenue (Total) Growth	-3.00%	1.10%	-0.21%

Gross Profit

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
North American OTC Healthcare Gross Margin	520.99M	531.14M	528.90M
North American OTC Healthcare Gross Margin Growth	-1.91%	0.42%	-0.57%
International OTC Healthcare Gross Margin	98.30M	103.32M	95.55M
International OTC Healthcare Gross Margin Growth	-4.86%	8.14%	2.34%
Gross Profit (Total)	619.29M	634.46M	624.45M
Gross Profit (Total) Growth	-2.39%	1.60%	-0.14%

Adjusted Gross Profit

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
North American OTC Healthcare Contribution Margin	397.52M	401.71M	397.41M
North American OTC Healthcare Contribution Margin Growth	-1.04%	1.08%	-2.60%
International OTC Healthcare Contribution Margin	71.07M	77.03M	73.73M
International OTC Healthcare Contribution Margin Growth	-7.74%	4.48%	2.08%
Gross Profit (Other)	150.70M	155.72M	153.32M
Gross Profit (Total)	619.29M	634.46M	624.45M
Gross Profit (Total) Growth	-2.39%	1.60%	-0.14%

Updated Dec 31, 2025. Data Source: Fiscal.ai.